HEALWELL AI’s Pentavere Partners with Sunnybrook and Successfully Demonstrates its AI Powered Clinician Co-pilot System Can Improve Cancer Staging in Prestigious Peer-Reviewed Medical Journal
TORONTO, May 21, 2024 (GLOBE NEWSWIRE) — HEALWELL AI Inc. (“HEALWELL” or the “Company”) (TSX:AIDX) (OTCQX: HWAIF), a data science and AI company focused on preventative care, is pleased to announce that its subsidiary Pentavere Research Group Inc. (“Pentavere”), has partnered with Sunnybrook Health Sciences Centre and Dr. Tony Eskander, a globally recognized head and neck surgical oncologist to demonstrate how Pentavere’s DARWEN™ AI platform can help improve cancer staging to support treatment decisions and improve patient outcomes.
Related news for (HWAIF)
- HEALWELL AI Leverages Orion Health to Power Entry into US Market
- WELL Health Reports HEALWELL AI and WELLSTAR Subsidiaries Are Selected for Canada Health Infoway’s Vendor Innovation Program
- HEALWELL AI to Announce Fiscal First Quarter 2025 Financial Results on May 13, 2025
- WELL Health to Exercise Call Right and Acquire Majority Controlling Interest in HEALWELL AI concurrent with HEALWELL’s Proposed Acquisition of Orion Health
- HEALWELL AI to Announce Fourth Quarter and Year End 2024 Financial Results on March 26, 2025